Article Details
Retrieved on: 2022-01-29 15:42:21
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The shares of Abbott Laboratories (NYSE: ABT) have received a price target of $151 from Morgan Stanley. These are the details.
Article found on: pulse2.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here